Screener
Harmony Biosciences Holdings, Inc. HRMY EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net income | $32,488 | $45,560 |
| Unrealized (loss) income on investments | (759) | 179 |
| Comprehensive income | $31,729 | $45,739 |
| EARNINGS PER SHARE: | ||
| Basic | $0.56 | $0.79 |
| Diluted | $0.55 | $0.78 |
| Weighted average number of shares of common stock - basic | 57,819,060 | 57,309,938 |
| Weighted average number of shares of common stock - diluted | 58,776,297 | 58,524,566 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s EPS (diluted)?
- Harmony Biosciences Holdings, Inc. (HRMY) reported EPS (diluted) of $0.55 in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s EPS (diluted) changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s EPS (diluted) decreased by 29.5% year-over-year, from $0.78 to $0.55.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s EPS (diluted) has grown at a 47.2% compound annual growth rate (CAGR), from $0.58 to $2.72.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Harmony Biosciences Holdings, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude